nephrocalcinosis
Information
- Disease name
- nephrocalcinosis
- Disease ID
- DOID:12679
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04495608 | Active, not recruiting | Phase 2 | Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels | January 13, 2021 | July 2024 |
| NCT02438267 | Completed | Preterm Infants and Nephrocalcinosis | April 2015 | January 2017 | |
| NCT00249951 | Completed | Phase 3 | Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants | November 2005 | November 2008 |
| NCT04382976 | Completed | The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants | October 1, 2018 | October 1, 2021 | |
| NCT05862207 | Not yet recruiting | Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital | June 2023 | May 2024 | |
| NCT00169806 | Recruiting | N/A | Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis | November 1998 | December 2025 |
| NCT01756547 | Unknown status | Phase 3 | Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature | January 2013 | January 2014 |
| NCT00875823 | Withdrawn | International Registry for Primary Hyperoxaluria | September 2003 | July 2009 |
- Disase is a (Disease Ontology)
- DOID:557
- Cross Reference ID (Disease Ontology)
- GARD:7177
- Cross Reference ID (Disease Ontology)
- MESH:D009397
- Cross Reference ID (Disease Ontology)
- NCI:C84918
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154752005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0027709
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000121
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009397